# CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

> **NCT00710892** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Baylor College of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Non-Hodgkin's Lymphoma
- Myelodysplastic Syndrome
- Chronic Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** Allodepleted T Cells

## Key facts

- **NCT ID:** NCT00710892
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2008-12
- **Primary completion:** 2011-11
- **Final completion:** 2026-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00710892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00710892, "CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00710892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*